Drug Safety Business: Start-Up With AERS Filter Eyes Bisphosphonate Events

A small start-up company has developed a technique to filter the data in FDA’s Adverse Events Reporting System (AERS) database, which it says provides a more accurate analysis of adverse event reports.

More from Archive

More from Pink Sheet